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Aim To provide an overview of the lung cancer incidence 
trends in the City of Zagreb (Zagreb), Split-Dalmatia Coun-
ty (SDC), and Croatia in the period from 2001 to 2013.
Method Incidence data were obtained from the Croatian 
National Cancer Registry. For calculating incidence rates 
per 100 000 population, we used population estimates for 
the period 2001-2013 from the Croatian Bureau of Statis-
tics. Age-standardized rates of lung cancer incidence were 
calculated by the direct standardization method using 
the European Standard Population. To describe incidence 
trends, we used joinpoint regression analysis.
Results Joinpoint analysis showed a statistically signifi-
cant decrease in lung cancer incidence in men in all re-
gions, with an annual percentage change (APC) of -2.2% 
for Croatia, 1.9% for Zagreb, and -2.0% for SDC. In women, 
joinpoint analysis showed a statistically significant increase 
in the incidence for Croatia, with APC of 1.4%, a statistically 
significant increase of 1.0% for Zagreb, and no significant 
change in trend for SDC. In both genders, joinpoint analy-
sis showed a significant decrease in age-standardized inci-
dence rates of lung cancer, with APC of -1.3% for Croatia, 
-1.1% for Zagreb, and -1.6% for SDC.
Conclusion There was an increase in female lung can-
cer incidence rate and a decrease in male lung cancer in-
cidence rate in Croatia in 2001-20013 period, with similar 
patterns observed in all the investigated regions. These re-
sults highlight the importance of smoking prevention and 
cessation policies, especially among women and young 
people.
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Lung cancer is the most common cancer in the world, with 
1.8 million new cases diagnosed in 2012 and accounting 
for 12.9% of total cancer incidence (1). In terms of mortal-
ity, 1.6 million deaths were caused by lung cancer in 2012, 
accounting for 19.4% of total cancer deaths (1). Given the 
great public health burden imposed by lung cancer and the 
large differences in the incidence of lung cancer in various 
areas or within different time periods due to changing pop-
ulation structure and varying levels of smoking exposure, it 
is imperative to continuously monitor and assess data on 
epidemiological indicators. In 2012, Croatia was among 20 
countries with the highest incidence of lung cancer in the 
world: the incidence rate (age-standardized to standard 
world population; ASR-W) was 34.3 per 100 000 persons (1). 
According to the most recent data available from the Croa-
tian National Cancer Registry, in 2013, lung cancer was the 
most common cancer in men with crude incidence rate of 
99.9/100 000 persons and the third most common cancer 
in women with crude incidence rate of 33.2/100 000 per-
sons (2). Crude mortality rate in 2013 was 101.8/100 000 
persons for men and 32.3/100 000 for women (2).
Lung cancer incidence largely mirrors smoking preva-
lence, with a latency period of several decades (3). Tobacco 
smoking and exposure to environmental tobacco smoke 
is a proven cause of lung cancer (4). Cigarette smoking ac-
counts for approximately 80% of lung cancer cases in men 
and 50% of lung cancer cases in women worldwide (5). 
Lung cancer is also caused by secondhand tobacco smoke, 
with estimated 21 400 lung cancer deaths in non-smokers 
annually (6). Other risk factors for lung cancer include in-
door air pollution because of unventilated combustion of 
coal in households for heating and cooking; outdoor air 
pollution; occupational exposure to hazardous chemicals, 
such as in coal gasification and aluminum production; ex-
posure to radiation from indoor radon released from soil 
and building materials, and exposure to asbestos, silica 
dust, and several elements, including arsenic (7). Only a 
small number of patients diagnosed and treated for lung 
cancer have never smoked tobacco according to a study 
conducted on 212 newly diagnosed lung cancer patients 
at a tertiary level hospital in Zagreb (8).
Lung cancer is the leading cause of the years of life lost be-
cause of cancer and is associated with the highest econom-
ic burden relative to other cancer types. Thus, it represents a 
major public health problem. However, according to avail-
able data, the level of world research output on lung cancer 
lags significantly behind research on other malignancies (9). 
To achieve improved outcomes of lung cancer, more stud-
ies and research are necessary. We wanted to emphasize the 
importance of this public health issue and elucidate recent 
changes in the burden of lung cancer in Croatia.
Specifically, our aim was to assess trends of lung cancer in-
cidence in two Croatian counties with two largest cities in 
Croatia: the City of Zagreb (Zagreb) in the continental part 
of Croatia and Split-Dalmatia County (SDC), with Split as its 
capital, in coastal part of Croatia in the period from 2001 to 
2013 and trends in the entire country, emphasizing pos-
sible regional and gender-specific differences.
MATERIAL AND METHODS
Data sources
The incidence data for the period 2001-2013 were obtained 
from the Croatian National Cancer Registry (CNCR). Lung 
cancer was defined according to the International Classifi-
cation of Diseases (ICD), 10th Revision, codes C33 and C34, 
including malignant neoplasms of the trachea, bronchus, 
and lung. CNCR, founded in 1959, covers the whole Croatian 
population of approximately 4.2 million people and relies on 
mandatory cancer notifications from primary and secondary 
health care sources, copies of pathological findings from pa-
thology departments, and death certificates from the Croa-
tian Bureau of Statistics. Data from the CNCR are included 
in the Cancer Incidence in Five Continents publications. For 
calculating incidence rates per 100 000 population, we used 
population estimates for years 2001-2013 from the Croatian 
Bureau of Statistics. For age-standardized rates (ASR), we 
used the European standard population (10).
Statistical analysis
Age-standardized rates of lung cancer incidence (ASR-E) 
in Zagreb, SDC, and Croatia were calculated by the direct 
standardization method using the European Standard 
Population from year 1976 as a reference (10).
To describe incidence and mortality time trends, we car-
ried out joinpoint regression analysis of age-standardized 
rates using Joinpoint Regression Program, Version 4.5.0.0, 
from 2017. This approach takes rates of events – in this case, 
age-standardized cancer incidence rates – and tries to fit 
the simplest model possible, starting with the model with 
zero joinpoints (11). Using Monte Carlo Permutation meth-
od, this approach tests whether adding additional join-
points (up to a previously defined maximum) is statisti-
cally significant. It allows the user to see if the change 
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in trend is statistically significant. For the period between 
two joinpoints (or the beginning and the end of series), a 
log-linear model with annual percent change (APC) is cal-
culated as a trend measure, with its corresponding confi-
dence intervals (CI).
This analysis included logarithmic transformation of the 
rates, standard error for heteroscedasticity, maximum num-
ber of two joinpoints, a minimum of four years between two 
joinpoints, and a minimum of three years between a join-
point and beginning or the end of the series. A permutation 
test was used with statistical significance set at P < 0.05.
In describing trends, the terms “significant increase” or “sig-
nificant decrease” signify that the slope of the trend was 
statistically significant (P < 0.05), with CI not including zero, 




The overall number of diagnosed lung cancer cases in Cro-
atia decreased from 2428 in 2001 to 2051 in 2013, which 
was a decline of 15.5%. The number of diagnosed lung 
cancer cases in the City of Zagreb decreased from 397 
to 360 in the same time period, representing a decline of 
-9.3%. In SDC, there was a small increase in the number 
of lung cancer cases from 202 in 2001 to 207 in 2013, ie, a 
+2.5% increase (Table 1). Age-standardized rates declined 
in all regions.
TAbLE 1.  Lung cancer incidence in Zagreb, Split-Dalmatia County (SDC), and Croatia in the period 2001-2013
Incidence
Zagreb Split-Dalmatia County Croatia
Year No. of cases ASR* IR‡ No. of cases ASR* IR‡ No. of cases ASR* IR‡
Men
2001 397 97.9 109.8 202 89.6 95.6 2428 103.6 117.5
2002 421 103.3 116.7 190 82.8 89.1 2358 99.2 114.1
2003 343 83.9 95.0 199 85.0 92.7 2224 92.3 107.6
2004 337 80.7 93.1 228 93.6 105.5 2143 88.1 103.6
2005 405 95.8 111.6 258 105.9 118.3 2329 94.7 112.4
2006 368 85.1 101.2 215 86.7 97.9 2167 87.9 104.5
2007 355 82.0 97.3 242 93.8 109.8 2219 88.5 106.9
2008 323 72.3 88.2 215 82.8 97.3 040 80.3 98.2
2009 439 97.7 119.5 196 72.9 88.6 2242 87.3 108.0
2010 284 62.4 77.1 200 76.0 90.4 2033 78.3 98.2
2011 397 87.5 107.4 215 79.4 97.2 2175 83.3 105.4
2012 349 75.2 94.1 208 73.2 94.0 2088 78.0 101.4
2013 360 77.3 96.8 207 73.6 93.5 2051 76.6 99.9
Women
2001 142 25.8 34.7 60 23.0 26.8 548 18.2 24.5
2002 141 24.6 34.3 57 20.3 25.3 593 19.4 26.5
2003 147 25.4 35.7 55 18.9 24.2 555 17.5 24.8
2004 142 26.0 34.4 54 17.8 23.6 587 18.5 26.3
2005 151 26.6 36.5 81 28.2 35.1 646 20.6 28.9
2006 153 26.1 36.9 50 17.0 21.6 655 21.0 29.3
2007 124 21.5 29.8 70 22.0 30.1 572 17.8 25.6
2008 124 19.3 29.7 57 16.7 24.5 519 15.7 23.2
2009 183 30.0 43.8 53 16.6 22.7 706 21.4 31.7
2010 124 20.1 29.5 63 19.4 27.0 660 19.8 29.7
2011 199 32.1 47.3 73 21.9 31.3 772 22.8 34.8
2012 164 26.8 38.8 66 19.0 28.3 691 20.7 31.3
2013 174 29.3 41.1 70 20.4 30.0 730 21.8 33.2
ASR* - age standardized rate (using European standard population) per 100 000 population
IR‡ - crude incidence rate per 100 000 persons per year
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Men
Lung cancer ASR-E in men decreased from 97.9/100 000 
in 2001 to 77.3/100 000 in 2013 in Zagreb, from 89.6/100 
000 to 73.6/100 000 in SDC, and from 103.6/100 000 to 
76.6/100 000 in Croatia. A joinpoint analysis showed a sig-
nificant decrease in ASR-E in all analyzed regions, with the 
highest APC of -2.2% (95% CI, from -2.4% to -2.0%) for Croa-
tia, followed by APC of -2.0% (95% CI, from -2.4% to -1.5%) 
for SDC, and APC of -1.9% (95% CI, from -2.6% to -1.3%) for 
Zagreb (Table 2)
Women
In women, there was an increase in the number of new 
lung cancer cases in 2013 in comparison with 2001 for Cro-
atia (730/548, +33.2%), Zagreb (174/142, +22.5%), and SDC 
(70/60, +16.7%) (Table 1). Lung cancer ASR-E in women in 
Croatia increased from 18.2/100 000 in 2001 to 21.8/100 
000 in 2013 and in women in Zagreb, it increased from 
25.8/100 000 in 2001 to 29.3/100 000 in 2013. In women in 
SDC, it decreased from 23.0/100 000 to 20.4/100 000 in the 
same time period.
Joinpoint analysis showed a significant increase in the 
ASR-E of lung cancer in women for Croatia (Table 2). There 
was also a significant increase in the ASR-E of lung cancer 
in women Zagreb, but no statistically significant change in 
trend was found for women in SDC.
In terms of both sexes, joinpoint analysis showed a signifi-
cant decrease in ASR-E of lung cancer for entire Croatia, the 
city of Zagreb, and SDC (Table 2).
DISCUSSION
This is the first study to simultaneously assess trends in in-
cidence rates of lung cancer in different regions of Croatia. 
It shows that there is an overall decreasing trend in lung 
cancer incidence in Croatia, with still opposing trends in 
men and women, as discussed in a study by Janković et 
al (12). However, according to GLOBOCAN 2012, Croatia is 
still among the European countries with the highest lung 
cancer incidence and mortality rate, especially in men (2). 
Quality of lung cancer data collection and reporting var-
ies between countries due to the variation in the existence 
and quality of cancer registries, differences in the percent-
age of cases reported only by death certificates (DCO cas-
es) and challenges in determining primary cancer site in 
low-resource settings.
Our results show significant decrease in incidence rate for 
men in Zagreb, SDC, and overall Croatia and significant 
increase for women in Zagreb and Croatia. In our study, 
incidence rates were considerably lower among women, 
which is associated with a lower smoking prevalence in 
women (13), but our study also showed diverging time 
trends of lung cancer incidence in men and women. A 
previous study has suggested that a higher proportion 
of women than men in Croatia are starting to smoke (14), 
so there is little probability that these worrying trends in 
women are likely to reverse in the years to come, unless 
comprehensive preventive measures are implemented.
It is estimated that tobacco smoke contains around 4800 
compounds of which about 100 are carcinogenic, muta-
genic or have tumor promoter properties (14). Recent data 
indicate that more than one-quarter of adult inhabitants of 
Croatia are everyday smokers, which presents a great pub-
lic health problem (15). The Croatian Adult Health Survey 
(CAHS) performed in 2003 suggested regional differences 
in smoking prevalence and a higher prevalence in men. 
However, regional difference in smoking prevalence be-
tween the City of Zagreb and Adriatic region was not signif-
icant. The greatest gender differences were recorded in the 
City of Zagreb, with a strong women predominance pat-
tern (13). This could be related to the modifying effects of 
the level of urbanization associated with the weakening the 
conservative and traditional opinions and lifestyle patterns.
By ratifying the World Health Organization’s Framework 
Convention for Tobacco Control (WHO FCTC), Croatia in-
tegrated European tobacco bans into Croatian Act on 
the restriction of the use of tobacco products: re-
TAbLE 2. Joinpoint analysis of age-standardized rates of lung 
cancer incidence in men and women of all ages in Zagreb, 
Split-Dalmatia County, and Croatia, 2001-2013*
Region Sex APC 95% CI
ZG M -1.9 -2.6 - -1.3
ZG F 1.0  0.3 - 1.8
ZG M/F -1.1 -1.7 - -0.5
SDC M -2.0 -2.4 - -1.5
SDC F -0.8 -1.6 - 0.0
SDC M/F -1.6 -2.1 - -1.1
Cro M¶ -2.2 -2.4 - -2.0
Cro F 1.4  1.0 - 1.9
Cro M/F -1.3 -1.5 - -1.0
*Abbreviations: APC - annual percentage change, CI –confidence in-
terval, ZG – Zagreb, M – male, F – female, SDC – Split-Dalmatia County, 
Cro – Croatia.
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stricted areas for smokers, limitation of tar and nicotine lev-
els, and advertising forbidden through the country. How-
ever, there is a problem with its implementation, meaning 
that the smoking is still allowed in most of the bars and ca-
fes (16). Better law enforcement would certainly contribute 
to further reducing the prevalence of smoking.
Croatia should look up to countries who have the most 
comprehensive tobacco control measures (eg, the Unit-
ed Kingdom), which include high prices, comprehensive 
smoke free legislation, comprehensive advertising bans, 
and pictorial health warnings (17). Raising taxes to increase 
tobacco product prices is the most effective and cost-ef-
ficient means of reducing tobacco use and encouraging 
users to quit, but it is one of the least used tobacco control 
measures (18). Croatia should also have better programs to 
help people who want to quit smoking framed within an 
integrated strategy or a national plan.
According to the Association of European Cancer Leagues 
(17), future steps in tobacco control that could be appli-
cable for Croatia include implementation of a comprehen-
sive tobacco control policy in its tobacco control program, 
which is an obligation under Article 4 of the WHO FCTC, 
with the introduction of various measures defined in the 
convention. Other possible measures include investing 
more in public awareness campaigns, which should be or-
ganized annually to ensure that they reach more patients at 
the right time, establishing better control of tobacco sales 
to minors, and consider and debate about implementing 
screening methods, such as low dose computed tomogra-
phy (LDCT) given that some studies show potential ben-
efits of this screening method (19). There should also be a 
better control of tobacco sales to minors. Those measures 
have been proven to be effective to reduce smoking.
Our study showed an increase in female lung cancer inci-
dence rate and a decrease in male lung cancer incidence 
rate in Croatia. Despite that, Croatia is still among the Eu-
ropean countries with the highest lung cancer incidence. 
Given the high incidence and mortality rate of lung cancer 
in Croatia, introducing a comprehensive tobacco control 
program, especially among young people and women, is 
of utmost importance.
Possible limitations of our study include uneven and de-
layed reporting of lung cancer cases in Croatia in some 
years that may reflect in larger rate variations than ex-
pected. Short time frame of the study is also one of the 
possible limitations.
Different measures likely have synergistic effects, and the 
consensus is that a comprehensive, multi-stakeholder ap-
proach is the most effective means of reducing tobacco 
consumption. The differences in trend between two larg-
est Croatian counties, and differences in comparison of 
both overall incidence and incidence trends to overall data 
for Croatia, warrant further studies extended to other Croa-
tian areas, in order to elucidate factors that might contrib-
ute to these differences and to tailor preventive programs 
accordingly.
Acknowledgment We thank Petra Čukelj for help with the editing of the 
manuscript.
Ethical approval Not required.
Funding None declared.
Declaration of authorship SKJ participated in data collection, data analysis, 
interpretation of the results, study design and coordination, manuscript ed-
iting, and review. PVM participated in data collection, interpretation of the 
results, study design, and manuscript editing. TI participated in data collec-
tion, data analysis, and manuscript editing. ŠM participated in data collec-
tion, data analysis, interpretation of the results and manuscript editing and 
review. KS participated in manuscript editing and review, interpretation of 
the results, and study design.
Competing interests All authors have completed the Unified Competing 
Interest form at www.icmje.org/coi_disclosure.pdf (available on request 
from the corresponding author) and declare: no support from any organi-
zation for the submitted work; no financial relationships with any organiza-
tions that might have an interest in the submitted work in the previous 3 
years; no other relationships or activities that could appear to have influ-
enced the submitted work.
References
1 Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo 
M, et al. Cancer incidence and mortality worldwide: sources, 
methods and major patterns in GLObOCAN 2012. Int J Cancer. 
2015;136:E359-86. Medline:25220842 doi:10.1002/ijc.29210
2 Croatian National Cancer Registry. Croatian Institute of Public 
Health. Cancer incidence in Croatia 2012. bulletin No.37. Zagreb: 
Croatian Institute of Public Health; 2014.
3 bilello KS, Murin S, Matthay RA. Epidemiology, etiology, and 
prevention of lung cancer. Clin Chest Med. 2002;23:1-25. 
Medline:11901905 doi:10.1016/S0272-5231(03)00057-1
4 Hackshaw AK, Law MR, Wald NJ. The accumulated evidence 
on lung cancer and environmental tobacco smoke. bMJ. 
1997;315:980-8. Medline:9365295 doi:10.1136/bmj.315.7114.980
5 Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global 
burden of cancer: priorities for prevention. Carcinogenesis. 
2010;31:100-10. Medline:19934210 doi:10.1093/carcin/bgp263
6 Oberg M, Jaakkola MS, Woodward A, Peruga A, Pruss-Ustun A. 
Worldwide burden of disease from exposure to second-hand 
smoke: a retrospective analysis of data from 192 countries. 
Lancet. 2011;377:139-46. Medline:21112082 doi:10.1016/S0140-
6736(10)61388-8
7 Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality 
and smoking prevalence. Transl Lung Cancer Res. 2015;4:327-38. 
363Siroglavić et al: Incidence of lung cancer in Croatia, 2001-2013
www.cmj.hr
Medline:26380174
8 Kukulj S, Popovic F, budimir b, Drpa G, Serdarevic M, Polic-Vizintin 
M. Smoking behaviors and lung cancer epidemiology; a cohort 
study. Psychiatr Danub. 2014;26 Suppl 3:485-9. Medline:25536986
9 Aggarwal A, Lewison G, Idir S, Peters M, Aldige C, boerckel W, et al. 
The state of lung cancer research: a global analysis. J Thorac Oncol. 
2016;11:1040-50. Medline:27013405 doi:10.1016/j.jtho.2016.03.010
10 Waterhouse J, Correa P, Muir C, Powell J. Cancer incidence in five 
continents, Vol. III. IARC Sceintific Publications, No. 15. Lyon: IARC; 
1976. p. 456.
11 Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for 
joinpoint regression with applications to cancer rates. Stat Med. 
2000;19:335-51. Medline:10649300 doi:10.1002/(SICI)1097-
0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
12 Janković M, Samarzija M, Jakopovic M, Kulis T, Znaor A. Trends 
in lung cancer inicidence and mortality in Croatia, 1988 – 2008. 
Croat Med J. 2012;53:93-9. Medline:22522986 doi:10.3325/
cmj.2012.53.93
13 Samardžić S, Mravinac GV, Prlić A. Regional pattern of smoking in 
Croatia. Coll Antropol. 2009;33 Suppl 1:43-6. Medline:19563146
14 Samardžić S, Vuletić G, Tadijan D. Five-year cumulative incidence 
of smoking in adult Croatian population: the CroHort study. Coll 
Antropol. 2012;36 Suppl 1:99-103. Medline:22338755 doi:10.5671/
ca.2012361s.99
15 Kovačić L, Gazdek D, Samardžić S. Croatian health survey: cigarette 
smoking. Acta Med Croatica. 2007;61:281-5. Medline:17629103
16 World Health Organization, Regional Office for Europe. Tobacco 
Control Fact Sheet Croatia. Health impact of tobacco control 
policies in line with the WHO Framework Convention on Tobacco 
Control (WHO-FCTC). 2016. Available from: http://www.euro.who.
int/__data/assets/pdf_file/0004/312592/Tobacco-control-fact-
sheet-Croatia.pdf. Accessed: August 25, 2017.
17 Joossens L, Raw M. The Tobacco Control Scale 2013 in Europe. 
2014. Available from: http://www.europeancancerleagues.org/
images/TobaccoControl/TCS_2013_in_Europe_13-03-14_final_1.
pdf. Accessed: August 25, 2017.
18 World Health Organization. WHO report on the global tobacco 
epidemic, 2017. Monitoring tobacco use and prevention policies. 
2017. Available from: http://www.who.int/tobacco/global_
report/2017/en/. Accessed August 28, 2017.
19 Field JK, Duffy SW, baldwin DR, brain KE, Deveraj A, Eisen T, et al. 
The UK Lung Cancer Screening trial: a pilot randomized controlled 
trial of low – dose computed tomography screening for the early 
detection of lung cancer. Health Technol Assess. 2016;20:1-146. 
Medline:27224642 doi:10.3310/hta20400
